Real-Life Results after the Administration of a Single 0.19 mg Fluocinolone Acetonide (ILUVIEN<sup>®</sup>) Implant in Patients with Refractory Diabetic Macular Edema
Even though patients' visual recovery does not benefit significantly, the FAc implant addresses the important pillars of chronic DME therapy regarding reduced injection frequency and reduced DME.
Authors
- Warda Darwisch (ORCID: https://orcid.org/0000-0003-1980-4968)
- Maria della Volpe Waizel (ORCID: https://orcid.org/0000-0002-6588-4842)
- Annekatrin Rickmann (ORCID: https://orcid.org/0000-0003-1651-5714)
- Karl Boden (ORCID: https://orcid.org/0000-0003-0277-2525)
- Philipp Roberts
- Peter Szurman
Institutions
- Beiersdorf (Germany) (DE)
- Knappschaftsklinikum Saar (DE)
- STZ eyetrial (DE)
Publication Details
- Journal
- Ophthalmic Research
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1159/000540459
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00